Innovative solution optimizes laboratory workflow and clinical information management
bioMérieux Extends Portfolio of Full Micriobiology Lab Automation solutions at ASM General Meeting
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that it will present an expanded portfolio of microbiology laboratory automation solutions during the 110th General Meeting of the American Society for Microbiology (ASM) in San Diego, Calif.
bioMérieux Presents 2010 Sonnenwirth Award for Leadership in Clinical Microbiology to Patricia Charache
Charache to Give Accompanying Lecture during the American Society for Microbiology General Meeting on May 24th in San Diego
Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Micriobiology
Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology laboratories.
bioMérieux Co-Sponsors French Medical Days in Shanghai
bioMérieux plays a driving role in Sino-French healthcare cooperation: · Organization of seminar on emergency medicine · Inauguration of Sino-French Emergency Satellite Lab at Xinhua Hospital · Renewal and extension of the partnership with Fudan University Shanghai Cancer Hospital · Pilot project with the Shanghai Health Bureau on decentralized diagnostics in Community and County Healthcare Centers (CHC)
bioMérieux Strengthens North American Executive Management Team
Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc.
bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection
bioMérieux and GlaxoSmithKline (GSK) have signed an agreement to develop a novel molecular test for cancer. In this new collaboration, the two companies will develop a theranostic test to aid oncologists in choosing the appropriate treatment for metastatic melanoma (skin cancer).
bioMérieux and Knome Sign Strategic Partnership
Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market. bioMérieux takes equity stake in Knome.
bioMérieux - First Quarter 2010 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2010.
bioMérieux's 2010 Odyssey Hits the Road in the Battle Against Superbugs
High-tech Mobile Laboratory Brings Education and Training to Healthcare and Quality Assurance Professionals Across North America